Hepatitis C virus inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S252050, C514S255050, C514S256000, C514S292000, C514S326000, C514S333000, C514S341000, C514S364000, C514S365000, C514S383000, C514S397000, C544S124000, C544S238000, C544S333000, C544S405000, C546S210000, C546S256000, C546S274100, C548S133000, C548S146000, C548S265200, C548S314700

Reexamination Certificate

active

07659270

ABSTRACT:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

REFERENCES:
patent: 5654451 (1997-08-01), Kari
patent: 2004/0142985 (2004-07-01), Singh et al.
patent: 2005/0119318 (2005-06-01), Hudyma et al.
patent: WO 94/15909 (1994-07-01), None
patent: WO 2004/002940 (2004-01-01), None
patent: WO 2005/047288 (2005-05-01), None
patent: WO 2005/105761 (2005-11-01), None
patent: WO 2006/022442 (2006-03-01), None
patent: WO 2006/093867 (2006-09-01), None
patent: WO 2006/133326 (2006-12-01), None
patent: WO 2007/031791 (2007-03-01), None
patent: WO 2007/058384 (2007-05-01), None
patent: WO 2007/077186 (2007-07-01), None
patent: WO 2007/080401 (2007-07-01), None
patent: WO 2007/081517 (2007-07-01), None
patent: WO 2007/082554 (2007-07-01), None
patent: WO2007/138242 (2007-12-01), None
patent: WO2008/021927 (2008-02-01), None
patent: WO2008/021936 (2008-02-01), None
U.S. Appl. No. 12/120,494, filed May 14, 2008, Bachand, et al.
U.S. Appl. No. 12/030,232, filed Feb. 13, 2008, Bachand, et al.
U.S. Appl. No. 12/029,680, filed Feb. 12, 2008, Bachand et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hepatitis C virus inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis C virus inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4179450

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.